DLG-associated protein 2 (DLGAP2) is a member of the family of Discs Large (DLG) membrane-associated guanylate kinase (MAGUK) proteins. These proteins are typically involved in the formation and regulation of signaling complexes at cell junctions and are crucial for maintaining cell structure and function. DLGAP2, specifically, is known to play a role in the central nervous system.The DLGAP2 protein interacts with postsynaptic density proteins, such as PSD-95, which are integral to the structure and function of synaptic junctions in neurons. Synaptic junctions are the sites of signal transmission between neurons, and the proteins associated with these structures are pivotal for synaptic plasticity, which underlies learning and memory. DLGAP2 contributes to the scaffolding that organizes ion channels, receptors, and enzymes in close proximity to support effective signal transduction.
Variants in the gene encoding DLGAP2 have been implicated in neuropsychiatric disorders, such as autism spectrum disorders (ASDs) and schizophrenia. This association underscores the importance of the structural and signaling roles that DLGAP2 plays in synaptic function. Disruption of DLGAP2's normal function due to genetic mutations can lead to altered neuronal communication, which may contribute to the pathophysiology of these complex brain disorders.Research into DLGAP2 includes studies on its expression patterns, post-translational modifications, and interaction with other synaptic proteins. Understanding the precise molecular mechanisms by which DLGAP2 operates can provide insights into the regulatory processes of synaptic dynamics and the broader implications for neuronal circuitry and behavior.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(+)-Bicuculline | 485-49-4 | sc-202498 sc-202498A | 50 mg 250 mg | $82.00 $281.00 | ||
A GABA_A receptor antagonist, it increases neuronal excitability by inhibiting inhibitory synaptic transmission. | ||||||
6-Cyano-7-nitroquinoxaline-2,3-dione | 115066-14-3 | sc-505104 | 10 mg | $208.00 | 2 | |
An AMPA receptor antagonist, it inhibits excitatory glutamate signaling in synapses. | ||||||
Lamotrigine | 84057-84-1 | sc-201079 sc-201079A | 10 mg 50 mg | $120.00 $486.00 | 1 | |
Inhibits voltage-sensitive sodium channels, stabilizing presynaptic neuronal membranes and inhibiting glutamate release. | ||||||
Fluoxetine | 54910-89-3 | sc-279166 | 500 mg | $318.00 | 9 | |
A selective serotonin reuptake inhibitor, affecting serotonin signaling in synapses. | ||||||